rPeptide is a biotechnology company with offices located in and around Athens, Georgia, USA, and is a market leader in providing research products (recombinant peptides and proteins, antibodies, reagents) for Alzheimer's disease and Parkinson's disease research. rPeptide also provides a range of custom services from molecular biology, protein expression and purification, to 13C and 15N uniform labeling of peptides and proteins.
rPeptide has a proprietary platform vector technology that enables the expression of historically difficult peptides/proteins as soluble peptides/proteins (like beta-amyloid, leptin, pro-insulin) in E. coli.
rPeptide’s product line offers many Ultra Pure peptides and most products are ‘net peptide content’ and not ‘total content.’
No comments:
Post a Comment